We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS Rejects PhRMA Plea to Annul 340B Orphan Drug Discount Rule
HHS Rejects PhRMA Plea to Annul 340B Orphan Drug Discount Rule
HHS stands by its final rule expanding 340B discounts to orphan drugs when certain hospitals and healthcare providers use them to treat non-rare diseases, the agency said in a court filing opposing PhRMA’s attempts to invalidate the rule.